MiSight 1 Day Safety Post-Approval Study
This prospective post-approval study of safety in a US study population is to confirm the safety of MiSight 1 day lenses. Consecutive subjects receiving the MiSight 1 Day lens, who meet the inclusion criteria, will be prospectively offered to participate in the study. Additionally, safety data from the MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms (PAS001) will be used to supplement this safety study.
Phase
N/ASpan
250 weeksSponsor
Coopervision, Inc.Oviedo, Florida
Recruiting
Healthy Volunteers
Amplatzer Amulet LAAO Vs. NOAC
Phase
N/ASpan
530 weeksSponsor
Abbott Medical DevicesOviedo, Florida
Recruiting
Biopsychosocial Contributors to Irritability in Individuals With Shoulder Pain
Phase
N/ASpan
132 weeksSponsor
University of Central FloridaOrlando, Florida
Recruiting
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Phase
3Span
151 weeksSponsor
SanofiOviedo, Florida
Recruiting
1-4 of 4